2m 2m 2m 2m 2m 2m 2m
Spyre Therap (SYRE)
NASDAQ
$95.26+$1.53 (+1.64%)
Price as of Jul 14, 2026 5:38 AM EDT- $8.1BMarket Cap
- 471.18%1-Year Change
- BiotechnologyIndustry
Spyre Therap (SYRE)
$95.26+$1.53 (+1.64%)
SYRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $93.73 | ||
Change | -$4.01 (-4.10%) | ||
Open | $95.72 | ||
High | $96.81 | ||
Low | $92.67 | ||
Previous Close | $97.74 | ||
Volume | 1,038,857 | ||
30-Day Average Volume | 1,879,644 | ||
1-Week Change | 5.62% | ||
1-Month Change | 16.02% | ||
1-Year Change | 471.18% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 86.8M | ||
Total Assets | $764.0M | ||
Market Cap | $8.1B | ||
Enterprise Value | $8.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$69.0M | ||
Free Cash Flow | -$57.4M | ||
EBIT | -$69.0M | ||
EBITDA | -$69.0M | ||
Net Working Capital | $678.8M | ||
EPS | -$29.66 | ||
Enterprise Value/EBITDA | -117 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -142 | ||
Price/Operating Cash Flow | -142 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/08/2023 | ||
Earnings & Revenue